Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies
Clinical trial NCT02224599 · TERMINATED
Trial details
- NCT number
- NCT02224599
- Sponsor
- Kiromic BioPharma Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-28
- Primary completion
- 2018-08-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.